Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
Hot topic
REPORT
[New Resource] China Marketing Authorization Holder (MAH)'s Responsibilities for Drug Quality
Mar 24, 2023
INTERPRETATION
China Clinical Trial Application (CTA) / Investigational New Drug (IND) Application Procedures
Oct 20, 2022